Acrivon Therapeutics, Inc. ACRV 深 沪
等待开盘 08-14 09:30:00 美东时间
1.29
+0.040
+3.20%
华盛通- 最 高1.33
- 今 开1.27
- 成交量 14.24万股
- 最 低 1.25
- 昨 收 1.25
- 总市值 4044.85万
- 52周最高 10.16
- 市盈率 静 --
- 换手率 0.45%
- 52周最低 1.05
- 委 比 90.17%
- 总股本 3135.54万
- 历史最高 25.47
- 量 比 1.40
- 振 幅 6.40%
- 历史最低 1.05
- 每 手 1
- 风险率 2.84%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Jones Trading Downgrades Acrivon Therapeutics to Hold
Jones Trading analyst Soumit Roy downgrades Acrivon Therapeutics (NASDAQ:ACRV) from Buy to Hold.
05-17 04:33
Acrivon Therapeutics Q1 EPS $(0.51) Beats $(0.66) Estimate
Acrivon Therapeutics (NASDAQ:ACRV) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.66) by 22.73 percent. This is a 30.14 percent increase over losses of $(0.73) per share
05-15 04:28
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers icad (NASDAQ:ICAD) stock moved upwards by 73.0% to $3.34 during Wednes...
04-17 01:06
Acrivon Therapeutics Reports Progress in Cancer Drug Development
Acrivon Therapeutics, Inc. ( ($ACRV) ) has released its Q4 earnings. Here is a ...
04-08 11:51
美股大行评级 | 潜在涨幅686.94%！Sensei Biotherapeutics获Oppenheimer升目标价至4美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1112661771769712640.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Oppenheimer：维持Sensei Biotherapeutics(SNSE)"跑赢大市"评级，目标价从3.5美元升至4美元</p> <p>• 富国银行：上调Regulus Therapeutics(RGLS)评级至
03-29 18:13
Acrivon Therapeutics reports Q4 results
Acrivon Therapeutics press release (NASDAQ:ACRV): Q4 GAAP EPS of -$0.60. As of December 31, 2024, the company had cash, cash equivalents and investments of $184.6 million, which is expected to fund op...
03-28 17:20
美股大行评级 | 潜在涨幅706.45%！Guggenheim上调InflaRx目标价至10美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1111936502896275457.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持InflaRx(IFRX)"买入"评级，目标价从7美元升至10美元</p> <p>• Oppenheimer：维持Corvus Pharma(CRVS)"跑赢大市"评级，目标价从14美元升至15美
03-27 09:48
Acrivon Therapeutics Appoints New Chief Financial Officer
Acrivon Therapeutics, Inc. ( ($ACRV) ) has issued an announcement. On March 14,...
03-15 04:59
Top-rated biotechs with negative enterprise values
After four consecutive years of underperformance, biotech stocks are among the most unloved segments in the market. Major industry benchmarks SPDR S&P Biotech ETF (NYSEARCA:XBI) and the iShares Biotec...
03-02 03:28
快讯 | Acrivon Therapeutics宣布FDA已授予Acr-368肿瘤签名检测的突破性医疗器械认定，用于子宫内膜癌
Acrivon Therapeutics Announces FDA Has Granted Breakthrough Device Designation ...
02-05 21:00
